BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31788496)

  • 1. Selection of an Efficient AAV Vector for Robust CNS Transgene Expression.
    Hanlon KS; Meltzer JC; Buzhdygan T; Cheng MJ; Sena-Esteves M; Bennett RE; Sullivan TP; Razmpour R; Gong Y; Ng C; Nammour J; Maiz D; Dujardin S; Ramirez SH; Hudry E; Maguire CA
    Mol Ther Methods Clin Dev; 2019 Dec; 15():320-332. PubMed ID: 31788496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
    Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
    Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature.
    Ramirez SH; Hale JF; McCarthy S; Cardenas CL; Dona KNUG; Hanlon KS; Hudry E; Cruz D; Ng C; Das S; Nguyen DM; Nammour J; Bennett RE; Andrews AM; Musolino PL; Maguire CA
    Hum Gene Ther; 2023 Aug; 34(15-16):682-696. PubMed ID: 37376759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning.
    Nonnenmacher M; Wang W; Child MA; Ren XQ; Huang C; Ren AZ; Tocci J; Chen Q; Bittner K; Tyson K; Pande N; Chung CH; Paul SM; Hou J
    Mol Ther Methods Clin Dev; 2021 Mar; 20():366-378. PubMed ID: 33553485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction.
    Santoscoy MC; Espinoza P; De La Cruz D; Mahamdeh M; Starr JR; Patel N; Maguire CA
    Mol Ther Methods Clin Dev; 2023 Jun; 29():532-540. PubMed ID: 37359416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord.
    Hanlon KS; Cheng M; Ferrer RM; Ryu JR; Lee B; De La Cruz D; Patel N; Espinoza P; Santoscoy MC; Gong Y; Ng C; Nguyen DM; Nammour J; Clark SW; Heine VM; Sun W; Kozarsky K; Maguire CA
    Mol Ther; 2024 Jun; ():. PubMed ID: 38845196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates.
    Wang D; Li S; Gessler DJ; Xie J; Zhong L; Li J; Tran K; Van Vliet K; Ren L; Su Q; He R; Goetzmann JE; Flotte TR; Agbandje-McKenna M; Gao G
    Mol Ther Methods Clin Dev; 2018 Jun; 9():234-246. PubMed ID: 29766031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
    Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
    Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
    Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
    Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS.
    Kanaan NM; Sellnow RC; Boye SL; Coberly B; Bennett A; Agbandje-McKenna M; Sortwell CE; Hauswirth WW; Boye SE; Manfredsson FP
    Mol Ther Nucleic Acids; 2017 Sep; 8():184-197. PubMed ID: 28918020
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hanlon KS; Cheng M; De La Cruz D; Patel N; Santoscoy MC; Gong Y; Ng C; Nguyen DM; Nammour J; Clark SW; Kozarsky K; Maguire CA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
    Yang L; Li J; Xiao X
    Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice.
    Drouyer M; Merjane J; Nazareth D; Knight M; Scott S; Liao SHY; Ginn SL; Zhu E; Alexander IE; Lisowski L
    Mol Ther; 2024 Mar; 32(3):818-836. PubMed ID: 38297833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.
    Zhang L; Rossi A; Lange L; Meumann N; Koitzsch U; Christie K; Nesbit MA; Moore CBT; Hacker UT; Morgan M; Hoffmann D; Zengel J; Carette JE; Schambach A; Salvetti A; Odenthal M; Büning H
    Hum Gene Ther; 2019 Oct; 30(10):1284-1296. PubMed ID: 31407607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
    Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
    Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid.
    Goertsen D; Goeden N; Flytzanis NC; Gradinaru V
    Mol Ther Methods Clin Dev; 2022 Sep; 26():331-342. PubMed ID: 35990749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.